Chih-Wei Lin
Overview
Explore the profile of Chih-Wei Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tzou F, Chuang P, Hsu C, Wu C, Hsiao Y, Liu C, et al.
Biochim Biophys Acta Mol Basis Dis
. 2025 Feb;
1871(5):167736.
PMID: 39965731
Variants in the CRB1 gene cause retinal degeneration and subsequent vision impairment in patients of retinitis pigmentosa (RP). No treatments are currently available to cure or impede the progression of...
2.
Song C, Lin C, Han K
FASEB J
. 2025 Feb;
39(4):e70402.
PMID: 39953793
Cell cycle arrest and programmed cell death are crucial biological processes in cancer development. Regulating cell fate decisions is essential due to their potential to induce cell cycle arrest and...
3.
Lin C, Chen W, Lin Y, Tsao P, Lee Y, Juan C, et al.
J Chin Med Assoc
. 2025 Feb;
PMID: 39934974
Background: Pediatric drug intoxication is a significant public health issue worldwide. The present study aimed to delineate the epidemiology, exposure-related conditions, and outcome severity of pediatric drug intoxication cases in...
4.
Nagase M, Houk B, Vuu I, Cardona P, Dutta S, Lin C
AAPS J
. 2025 Jan;
27(1):26.
PMID: 39806205
Sotorasib is a novel KRAS inhibitor that has shown robust efficacy, safety, and tolerability in patients with KRAS mutation. The objectives of the population pharmacokinetic (PK) analysis were to characterize...
5.
Usama M, Hsu Y, Safaei M, Chen C, Han K, Ho Y, et al.
Cancer Lett
. 2025 Jan;
611():217453.
PMID: 39798832
Although breast cancer treatment has evolved significantly in recent years, drug resistance remains a major challenge. To identify new targets for breast cancer, we found that stage-specific embryonic antigen 4...
6.
Tseng C, Lin C, Tsai P, Su M
Microorganisms
. 2025 Jan;
12(12.
PMID: 39770769
Objectives: We aim to study the relative viral load using salivary polymerase chain reaction among pregnant women treated with Paxlovid. Methods: Pregnant women with coronavirus disease 2019 were allocated to...
7.
Lin C, Wu Y, Su P, Mau Y, Hsu C, Ou H, et al.
J Formos Med Assoc
. 2024 Dec;
PMID: 39632141
Background: Infertility and the economic burden of treatment can impose considerable psychosocial stress with negative consequences for the quality of life for all involved. The objective of this study was...
8.
Pourzanjani A, Modi S, Connarn J, Zhang X, Upreti V, Lin C, et al.
CPT Pharmacometrics Syst Pharmacol
. 2024 May;
13(8):1341-1353.
PMID: 38778515
Tumor growth inhibition (TGI) modeling attempts to describe the time course changes in tumor size for patients undergoing cancer therapy. TGI models present several advantages over traditional exposure-response models that...
9.
Jeng S, Tu M, Lin C, Lin J, Tseng H, Jang F, et al.
J Psychiatr Res
. 2024 Feb;
172:108-118.
PMID: 38373372
In the neurodevelopmental model of schizophrenia, minor physical anomalies (MPAs) are considered neurodevelopmental markers of schizophrenia. To date, there has been no research to evaluate the interaction between MPAs. Our...
10.
Azariah W, Bimo F, Lin C, Cheng R, Nikaein N, Jana R
Sensors (Basel)
. 2024 Feb;
24(3).
PMID: 38339755
The open radio access network (RAN) aims to bring openness and intelligence to the traditional closed and proprietary RAN technology and offer flexibility, performance improvement, and cost-efficiency in the RAN's...